Posters
- Home
- Education Events
- Posters
- Comprehensive genomic and immune profiling defines immunotherapy treatment in NSCLC patients with low PD L1 IHC
Comprehensive genomic and immune profiling defines immunotherapy treatment in NSCLC patients with low PD L1 IHC
02 Jun 2022